Published in J Virol on October 03, 2007
Quantitative 3D video microscopy of HIV transfer across T cell virological synapses. Science (2009) 3.69
HIV-1 assembly, budding, and maturation. Cold Spring Harb Perspect Med (2012) 3.17
Functional anatomy of T cell activation and synapse formation. Annu Rev Immunol (2010) 3.01
Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J Virol (2009) 2.33
Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition. J Virol (2010) 2.12
HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J Mol Biol (2011) 2.01
Cell-to-cell transfer of HIV-1 via virological synapses leads to endosomal virion maturation that activates viral membrane fusion. Cell Host Microbe (2011) 1.97
Virus cell-to-cell transmission. J Virol (2010) 1.84
Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells. J Virol (2010) 1.83
3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proc Natl Acad Sci U S A (2010) 1.52
Nucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cells. PLoS Pathog (2010) 1.31
Cell-to-Cell Spread of Retroviruses. Viruses (2010) 1.27
Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection. J Exp Med (2011) 1.22
New insights into HIV assembly and trafficking. Physiology (Bethesda) (2011) 1.18
Human immunodeficiency virus type 1 envelope gp120 induces a stop signal and virological synapse formation in noninfected CD4+ T cells. J Virol (2008) 1.16
Relationships between plasma membrane microdomains and HIV-1 assembly. Biol Cell (2010) 1.16
High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse. J Virol (2013) 1.15
HIV transfer between CD4 T cells does not require LFA-1 binding to ICAM-1 and is governed by the interaction of HIV envelope glycoprotein with CD4. Retrovirology (2008) 1.14
Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice. J Virol (2012) 1.14
The regulated secretory pathway in CD4(+) T cells contributes to human immunodeficiency virus type-1 cell-to-cell spread at the virological synapse. PLoS Pathog (2011) 1.13
HIV-1 transmission biology: selection and characteristics of infecting viruses. J Infect Dis (2010) 1.11
Biology of HIV mucosal transmission. Curr Opin HIV AIDS (2008) 1.06
Intercellular adhesion molecule 1 (ICAM-1), but not ICAM-2 and -3, is important for dendritic cell-mediated human immunodeficiency virus type 1 transmission. J Virol (2009) 1.04
The virological synapse facilitates herpes simplex virus entry into T cells. J Virol (2009) 1.03
Pathways of cell-cell transmission of HTLV-1. Front Microbiol (2012) 1.02
HIV-1 Virological Synapse: Live Imaging of Transmission. Viruses (2010) 1.01
HIV-1 induced bystander apoptosis. Viruses (2012) 1.01
Role of HIV Gp41 mediated fusion/hemifusion in bystander apoptosis. Cell Mol Life Sci (2008) 1.00
On the steps of cell-to-cell HIV transmission between CD4 T cells. Retrovirology (2009) 0.99
Cell-to-Cell Transmission of HIV-1 Is Required to Trigger Pyroptotic Death of Lymphoid-Tissue-Derived CD4 T Cells. Cell Rep (2015) 0.97
Productive entry of HIV-1 during cell-to-cell transmission via dynamin-dependent endocytosis. J Virol (2013) 0.96
Contact-induced mitochondrial polarization supports HIV-1 virological synapse formation. J Virol (2014) 0.95
HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse. Viruses (2010) 0.94
Cell-to-cell transmission of retroviruses: Innate immunity and interferon-induced restriction factors. Virology (2011) 0.93
HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA). PLoS One (2011) 0.92
HIV-1 assembly at the plasma membrane. Vaccine (2010) 0.91
CD36-specific antibodies block release of HIV-1 from infected primary macrophages and its transmission to T cells. J Exp Med (2013) 0.90
HIV-1 interactions with cells: from viral binding to cell-cell transmission. Curr Protoc Cell Biol (2009) 0.90
HIV cell-to-cell transmission: effects on pathogenesis and antiretroviral therapy. Trends Microbiol (2015) 0.88
How HIV-1 takes advantage of the cytoskeleton during replication and cell-to-cell transmission. Viruses (2011) 0.88
Ezrin is a component of the HIV-1 virological presynapse and contributes to the inhibition of cell-cell fusion. J Virol (2014) 0.88
Intercellular adhesion molecule 1 promotes HIV-1 attachment but not fusion to target cells. PLoS One (2012) 0.88
Role of the C-terminal domain of the HIV-1 glycoprotein in cell-to-cell viral transmission between T lymphocytes. Retrovirology (2010) 0.86
Measles virus transmission from dendritic cells to T cells: formation of synapse-like interfaces concentrating viral and cellular components. J Virol (2012) 0.86
Unique features of HIV-1 spread through T cell virological synapses. PLoS Pathog (2014) 0.85
Origin of the transmitted virus in HIV infection: infected cells versus cell-free virus. J Infect Dis (2014) 0.85
Dendritic cell-lymphocyte cross talk downregulates host restriction factor SAMHD1 and stimulates HIV-1 replication in dendritic cells. J Virol (2014) 0.84
Dynamic Association between HIV-1 Gag and Membrane Domains. Mol Biol Int (2012) 0.84
LFA-1 antagonists as agents limiting human immunodeficiency virus type 1 infection and transmission and potentiating the effect of the fusion inhibitor T-20. Antimicrob Agents Chemother (2009) 0.84
T cell polarization at the virological synapse. Viruses (2010) 0.84
Actin-binding protein drebrin regulates HIV-1-triggered actin polymerization and viral infection. J Biol Chem (2013) 0.83
Neutralisation of HIV-1 cell-cell spread by human and llama antibodies. Retrovirology (2014) 0.83
P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection. J Virol (2014) 0.83
The infectious synapse formed between mature dendritic cells and CD4(+) T cells is independent of the presence of the HIV-1 envelope glycoprotein. Retrovirology (2013) 0.83
Cellular and viral mechanisms of HIV-1 transmission mediated by dendritic cells. Adv Exp Med Biol (2013) 0.83
The immunological synapse: the gateway to the HIV reservoir. Immunol Rev (2013) 0.82
Prostaglandin E2 reduces the release and infectivity of new cell-free virions and cell-to-cell HIV-1 transfer. PLoS One (2014) 0.81
Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapy. Curr Top Med Chem (2011) 0.80
Dissecting How CD4 T Cells Are Lost During HIV Infection. Cell Host Microbe (2016) 0.80
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4(+) T-cells. Retrovirology (2015) 0.80
Breast milk from Tanzanian women has divergent effects on cell-free and cell-associated HIV-1 infection in vitro. PLoS One (2012) 0.79
HIV-1 Nef promotes the localization of Gag to the cell membrane and facilitates viral cell-to-cell transfer. Retrovirology (2013) 0.78
Cell-to-cell contact facilitates HIV transmission from lymphocytes to astrocytes via CXCR4. AIDS (2015) 0.78
Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef. Future Virol (2012) 0.78
Antibody against integrin lymphocyte function-associated antigen 1 inhibits HIV type 1 infection in primary cells through caspase-8-mediated apoptosis. AIDS Res Hum Retroviruses (2012) 0.78
Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence. Viruses (2016) 0.77
PIP2: choreographer of actin-adaptor proteins in the HIV-1 dance. Trends Microbiol (2014) 0.76
LFA-1 Engagement Triggers T Cell Polarization at the HIV-1 Virological Synapse. J Virol (2016) 0.76
New Connections: Cell-to-Cell HIV-1 Transmission, Resistance to Broadly Neutralizing Antibodies, and an Envelope Sorting Motif. J Virol (2017) 0.75
A monoclonal antibody against lymphocyte function-associated antigen-1 decreases HIV-1 replication by inducing the secretion of an antiviral soluble factor. Virol J (2013) 0.75
HIV-1 Gag, Envelope, and Extracellular Determinants Cooperate To Regulate the Stability and Turnover of Virological Synapses. J Virol (2016) 0.75
Where in the Cell Are You? Probing HIV-1 Host Interactions through Advanced Imaging Techniques. Viruses (2016) 0.75
WFDC1 expression identifies memory CD4 T-lymphocytes rendered vulnerable to cell-cell HIV-1 transfer by promoting intercellular adhesive junctions. Retrovirology (2011) 0.75
HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4(+) T Cells by NK Cells. J Virol (2017) 0.75
Modeling Viral Spread. Annu Rev Virol (2016) 0.75
HIV-1 Activates T Cell Signaling Independently of Antigen to Drive Viral Spread. Cell Rep (2017) 0.75
Three-dimensional segregation of supramolecular activation clusters in T cells. Nature (1998) 14.14
A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol (1986) 7.71
Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science (2003) 5.19
HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med (2004) 5.08
Regulation of T-cell activation by the cytoskeleton. Nat Rev Immunol (2007) 3.19
Directed egress of animal viruses promotes cell-to-cell spread. J Virol (2002) 2.72
Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J Virol (1997) 2.54
Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J Exp Med (1992) 2.24
T-cell integrins: more than just sticking points. J Cell Sci (2003) 2.21
Retroviral spread by induction of virological synapses. Traffic (2004) 2.19
Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1. J Virol (2007) 2.18
The role of cell-to-cell transmission in HIV infection. AIDS (1994) 2.01
Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization. J Virol (1997) 1.72
T cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1. J Virol (1998) 1.48
The immunological synapse: integrins take the stage. Immunol Rev (2002) 1.47
Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. J Biol Chem (2005) 1.45
Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes. Blood (2005) 1.44
LFA-1 expression on target cells promotes human immunodeficiency virus type 1 infection and transmission. J Virol (2001) 1.26
Signaling through integrin LFA-1 leads to filamentous actin polymerization and remodeling, resulting in enhanced T cell adhesion. J Immunol (2002) 1.24
Presence of host ICAM-1 in human immunodeficiency virus type 1 virions increases productive infection of CD4+ T lymphocytes by favoring cytosolic delivery of viral material. J Virol (2003) 1.24
Characterization of lymphocyte function-associated antigen 1 (LFA-1)-deficient T cell lines: the alphaL and beta2 subunits are interdependent for cell surface expression. J Immunol (1997) 1.22
Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity. J Virol (1998) 1.18
Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses. J Exp Med (1994) 1.12
Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection. Virology (1999) 1.10
Regulation of LFA-1 activity through cytoskeleton remodeling and signaling components modulates the efficiency of HIV type-1 entry in activated CD4+ T lymphocytes. J Immunol (2005) 1.10
Regulation of expression of a human intercellular adhesion molecule (ICAM-1) during lymphohematopoietic differentiation. Blood (1989) 1.08
Dendritic cell-mediated HIV-1 transmission to T cells of LAD-1 patients is impaired due to the defect in LFA-1. Retrovirology (2006) 1.03
Trans-dominant cellular inhibition of DC-SIGN-mediated HIV-1 transmission. Retrovirology (2004) 1.02
Inhibition of the adherence of T-lymphocytes to epithelial cells by a cyclic peptide derived from inserted domain of lymphocyte function-associated antigen-1. Inflammation (2001) 0.88
Intercellular adhesion molecule 3, a candidate human immunodeficiency virus type 1 co-receptor on lymphoid and monocytoid cells. J Gen Virol (1995) 0.87
A dominant Jurkat T cell mutation that inhibits LFA-1-mediated cell adhesion is associated with increased cell growth. J Immunol (2001) 0.85
Structural recognition of an ICAM-1 peptide by its receptor on the surface of T cells: conformational studies of cyclo (1, 12)-Pen-Pro-Arg-Gly-Gly-Ser-Val-Leu-Val-Thr-Gly-Cys-OH. J Pept Res (1999) 0.85
The leukocyte function-associated antigen-1 (LFA-1)-binding site on ICAM-3 comprises residues on both faces of the first immunoglobulin domain. J Immunol (1998) 0.85
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. PLoS One (2010) 5.73
HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med (2004) 5.08
V3: HIV's switch-hitter. AIDS Res Hum Retroviruses (2005) 3.00
Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med (2013) 2.94
Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situ. PLoS Pathog (2006) 2.81
High multiplicity HIV-1 cell-to-cell transmission from macrophages to CD4+ T cells limits antiretroviral efficacy. AIDS (2013) 2.25
Retroviral spread by induction of virological synapses. Traffic (2004) 2.19
Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1. J Virol (2007) 2.18
Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition. J Virol (2010) 2.12
Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood (2008) 1.94
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens. Nat Biotechnol (2012) 1.90
Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity. J Virol (2005) 1.90
A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines. Nat Med (2006) 1.82
Human immunodeficiency virus type 1 assembly, budding, and cell-cell spread in T cells take place in tetraspanin-enriched plasma membrane domains. J Virol (2007) 1.73
Transcription-dependent gene looping of the HIV-1 provirus is dictated by recognition of pre-mRNA processing signals. Mol Cell (2008) 1.50
Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site. J Biol Chem (2005) 1.38
Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans. J Virol (2003) 1.26
Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity. J Mol Biol (2010) 1.22
High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse. J Virol (2013) 1.15
Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission. AIDS (2013) 1.13
The regulated secretory pathway in CD4(+) T cells contributes to human immunodeficiency virus type-1 cell-to-cell spread at the virological synapse. PLoS Pathog (2011) 1.13
Development of prophylactic vaccines against HIV-1. Retrovirology (2013) 1.12
Viral determinants of HIV-1 macrophage tropism. Viruses (2011) 1.03
The HIV-1-containing macrophage compartment: a perfect cellular niche? Trends Microbiol (2013) 1.02
Architecture and regulation of the HIV-1 assembly and holding compartment in macrophages. J Virol (2011) 1.00
Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine Design. J AIDS Clin Res (2012) 1.00
Cell-to-cell spread of HIV-1 and evasion of neutralizing antibodies. Vaccine (2013) 0.96
Comparative efficiency of HIV-1-infected T cell killing by NK cells, monocytes and neutrophils. PLoS One (2013) 0.95
Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins. J Virol (2005) 0.94
Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer. Vaccine (2010) 0.94
New templates for HIV-1 antibody-based vaccine design. F1000 Biol Rep (2010) 0.93
Reactive carbonyls are a major Th2-inducing damage-associated molecular pattern generated by oxidative stress. J Immunol (2011) 0.90
Multiple proviral integration events after virological synapse-mediated HIV-1 spread. Virology (2013) 0.89
Synergistic inhibition of HIV-1 infection by combinations of soluble polyanions with other potential microbicides. Antiviral Res (2007) 0.88
Interfacial metal and antibody recognition. Proc Natl Acad Sci U S A (2005) 0.88
Regulated secretion from CD4+ T cells. Trends Immunol (2007) 0.86
A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment. PLoS One (2011) 0.85
SDF-1/CXCL12 production by mature dendritic cells inhibits the propagation of X4-tropic HIV-1 isolates at the dendritic cell-T-cell infectious synapse. J Virol (2010) 0.83
Human monoclonal antibodies to HIV-1 gp140 from mice bearing YAC-based human immunoglobulin transloci. Protein Eng Des Sel (2011) 0.82
Attachment factors. Adv Exp Med Biol (2013) 0.81
Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread. Antimicrob Agents Chemother (2008) 0.80
Vaccinology: A sweet cleft in HIV's armour. Nature (2011) 0.80
A functional human IgM response to HIV-1 Env after immunization with NYVAC HIV C. AIDS (2007) 0.79
Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins. Clin Vaccine Immunol (2006) 0.79
Stabilized HIV-1 envelope glycoprotein trimers for vaccine use. Curr Opin HIV AIDS (2017) 0.76
Stabilized HIV-1 envelope glycoprotein trimers for vaccine use. Curr Opin HIV AIDS (2017) 0.75